Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Efficacy of Max-40279-01 in Patients With Advanced Gastric Cancer or Gastroesophageal Junction Cancer [Phase 2]

View source ↗

Summary

Phase 2 study investigating the safety and efficacy of Max-40279-01 in advanced gastric cancer or gastroesophageal junction cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Max-40279-01

Snippet

Sponsor: Maxinovel Pty., Ltd. | Conditions: Gastric Cancer, Gastroesophageal Junction Cancer | Phase 2 | Status: UNKNOWN